[HTML][HTML] Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
Introduction Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-
small cell lung cancer (NSCLC). Materials and Methods Odds ratios (OR) and hazard ratios …
small cell lung cancer (NSCLC). Materials and Methods Odds ratios (OR) and hazard ratios …
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis.
VW Zhu, JJ Zhao, Y Gao, NL Syn, SS Zhang… - Lung Cancer …, 2021 - europepmc.org
Materials and methods Odds ratios (OR) and hazard ratios (HR) of TE were calculated from
meta-analysis and time-to-event analysis respectively for either ALK+ or ROS1+ NSCLC …
meta-analysis and time-to-event analysis respectively for either ALK+ or ROS1+ NSCLC …
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
VW Zhu, JJ Zhao, Y Gao, NL Syn… - Lung cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-
small cell lung cancer (NSCLC). Materials and methods Odds ratios (OR) and hazard ratios …
small cell lung cancer (NSCLC). Materials and methods Odds ratios (OR) and hazard ratios …
[引用][C] Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
VW Zhu, JJ Zhao, Y Gao, NL Syn, SS Zhang, SHI Ou… - Lung Cancer, 2021 - cir.nii.ac.jp
[PDF][PDF] Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
VW Zhu, JJ Zhao, Y Gao, NL Syn, SS Zhang, SHI Ou… - researchgate.net
Introduction: Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-
small cell lung cancer (NSCLC). Materials and Methods: Odds ratios (OR) and hazard ratios …
small cell lung cancer (NSCLC). Materials and Methods: Odds ratios (OR) and hazard ratios …
[HTML][HTML] Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
VW Zhu, JJ Zhao, Y Gao, NL Syn, SS Zhang… - Lung …, 2021 - lungcancerjournal.info
Introduction Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-
small cell lung cancer (NSCLC). Materials and Methods Odds ratios (OR) and hazard ratios …
small cell lung cancer (NSCLC). Materials and Methods Odds ratios (OR) and hazard ratios …
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis
VW Zhu, JJ Zhao, Y Gao, NL Syn, SS Zhang, SHI Ou… - 2021 - scholarbank.nus.edu.sg
Introduction: Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-
small cell lung cancer (NSCLC). Materials and Methods: Odds ratios (OR) and hazard ratios …
small cell lung cancer (NSCLC). Materials and Methods: Odds ratios (OR) and hazard ratios …